Average Co-Inventor Count = 3.36
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Probiodrug Ag (6 from 71 patents)
2. Origenis Gmbh (6 from 6 patents)
3. Novartis Ag (4 from 3,923 patents)
4. Boston University (1 from 818 patents)
17 patents:
1. 12384788 - 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune disease
2. 10752624 - Kinase inhibitors
3. 10000482 - Kinase inhibitors
4. 9802937 - Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors
5. 9637491 - Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
6. 9499535 - Kinase inhibitors
7. 9155792 - RecA inhibitors with antibiotic activity, compositions and methods of use
8. 8962860 - Inhibitors of glutaminyl cyclase
9. 8889709 - Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
10. 8420684 - Inhibitors of glutaminyl cyclase
11. 8278345 - Inhibitors of glutaminyl cyclase
12. 7932255 - 2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators
13. 7741354 - Inhibitors of glutaminyl cyclase
14. 7728146 - Enzyme inhibitors
15. 7705037 - 1-substituted pyrrolidin-2-ones and use thereof as peptide deformylase inhibitors